A detailed history of Putnam Investments LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 195,072 shares of ITCI stock, worth $17.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
195,072
Previous 124,426 56.78%
Holding current value
$17.8 Million
Previous $6.48 Million 115.57%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$46.37 - $73.65 $3.28 Million - $5.2 Million
70,646 Added 56.78%
195,072 $14 Million
Q3 2023

Nov 14, 2023

BUY
$52.09 - $64.1 $877,612 - $1.08 Million
16,848 Added 15.66%
124,426 $6.48 Million
Q2 2023

Aug 14, 2023

BUY
$54.67 - $66.44 $5.88 Million - $7.15 Million
107,578 New
107,578 $6.81 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.62B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.